Drug intelligence / Profile preview

human umbilical mesenchymal stromal cord cells

Development stage
Unknown
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intramyocardial, Intra-arterial, Local Injection (tissue-specific), Intrathecal
01

Overview

Human umbilical mesenchymal stromal cord cells (*UC-MSCs* or *hUC-MSCs*) are **multipotent stromal cells** isolated from the connective tissue of the human umbilical cord. These cells are capable of differentiating into various lineages, including osteogenic, adipogenic, chondrogenic, neurogenic, and hepatic cells. Their primary mechanism of action involves **paracrine signaling** and **immunomodulation**, releasing bioactive molecules that promote tissue repair, dampen inflammation, and support regeneration in damaged tissues. UC-MSCs are derived from multiple compartments of the cord (Wharton’s jelly, perivascular region, sub-amnion, amnion membrane) and are mostly utilized in experimental and clinical trials for regenerative medicine, immunotherapy, cardiovascular disease, graft-versus-host disease (GvHD), neurological disorders, immune disorders, wound healing, and tissue restoration[1][2][3].

Other names
human umbilical cord mesenchymal stromal cellshuman umbilical cord-derived mesenchymal stem cellsUC-MSCshUC-MSCswharton’s jelly mesenchymal stromal cellswharton’s jelly mesenchymal stem cells

Beyond the preview

Go deeper on human umbilical mesenchymal stromal cord cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human umbilical mesenchymal stromal cord cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call